Radiomics of Immunotherapeutics Response Evaluation and Prediction

CompletedOBSERVATIONAL
Enrollment

285

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

February 25, 2020

Conditions
Solid TumorPredictive Cancer Model
Interventions
DIAGNOSTIC_TEST

Clinical

Clinical: A diagnostic model incorporating clinical variables (Age, Pathological diagnosis, level of serum tumor biomarkers etc.)

DIAGNOSTIC_TEST

Semantic

Semantic: A diagnostic model incorporating semantic radiological features (shape, location, border, density etc.)

DIAGNOSTIC_TEST

Radiomic

Radiomic: A diagnostic model incorporating quantitative radiomic features (histogram, texture, morphology etc.)

Trial Locations (1)

300060

Tianjin Medical University Cancer Institute And Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Chest Hospital

OTHER

collaborator

Shandong Tumor Hospital

OTHER

collaborator

West China Hospital

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Liaoning Cancer Hospital & Institute

OTHER

collaborator

Hubei Cancer Hospital

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER

NCT04079283 - Radiomics of Immunotherapeutics Response Evaluation and Prediction | Biotech Hunter | Biotech Hunter